Advertisement
Screener

Tilray Brands, Inc. (TLRY) Noncontrolling Interest, Increase from Subsidiary Equity Issuance

2.8 / 5 stars · 68/120 Roast Me

Tilray Brands, Inc. Noncontrolling Interest, Increase from Subsidiary Equity Issuance

Tilray Brands, Inc. (TLRY) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $52.99 million for the 12-month period ending 2022-05-31, per its 10-K filed 2024-07-30.

Discontinued › Shareholders' Equity

us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2024-07-30

  • Tilray Brands, Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2021-08-31 was $52.99M.
  • Tilray Brands, Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2022 was $52.99M.
  • Tilray Brands, Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2019 was $7.14M.
Period endNoncontrolling Interest, Increase from Subsidiary Equity Issuance 3 monthNoncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month
2022-05-31$52.99M
10-K · filed 2024-07-30
2021-08-31$52.99M
10-Q · filed 2023-04-10
2019-05-31$7.14M
10-K · filed 2021-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87